Table 1 Published data of pemphigus onset/flare following COV19 vaccination
From: Pemphigus vulgaris after the second dose of COVID-19 vaccination: a case report
Study | Age | Sex | Technology/Platform | Dose of vaccine | Diagnosis | New onset or flare | Latency |
|---|---|---|---|---|---|---|---|
Solimani et al. [3] | 40 | F | mRNA | 1 | PV | New onset | 5 days |
Thongprasom et al. [4] | 38 | F | Modified chimpanzee adenovirus | 1 | Oral pemphigus | New onset | 1 week |
Koutlas et al. [5] | 60 | M | mRNA | 2 | PV | New onset | 7 days |
Singh et al. [6] | 44 | M | Modified chimpanzee adenovirus | 2 | PV | New onset | 1 week |
Akoglu et al. [7] | 69 | F | Inactivated | 2 | PV | New onset | 1 week |
Hali et al. [8] | 50 | F | mRNA | 1 | PF | New onset | 15 days |
58 | F | mRNA | 1 | PV | New onset | 1 month | |
Lua et al. [9] | 83 | M | mRNA | 2 | PF | New onset | 2 days |
Calabria et al. [10] | 60 | F | mRNA | 2 | PV | New onset | 7 days |
Knechtl et al. [1] | 89 | M | mRNA | 2 | PV | New onset | 1 month |